The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Urokinase-Global Market Insights and Sales Trends 2025
Synopsis
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase market size is expected to reach US$ 64 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Urokinase in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Urokinase market. Urokinase Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Urokinase Solution segment is estimated at % CAGR for the next seven-year period.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Urokinase, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Urokinase market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Urokinase market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Urokinase sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Urokinase covered in this report include Syner-Med, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems and LIVZON, etc.
The global Urokinase market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
Global Urokinase market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Urokinase market, Segment by Type:
Urokinase Powder
Urokinase Solution
Global Urokinase market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Urokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase market size is expected to reach US$ 64 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Urokinase in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Urokinase market. Urokinase Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Urokinase Solution segment is estimated at % CAGR for the next seven-year period.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Urokinase, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Urokinase market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Urokinase market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Urokinase sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Urokinase covered in this report include Syner-Med, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems and LIVZON, etc.
The global Urokinase market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
Global Urokinase market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Urokinase market, Segment by Type:
Urokinase Powder
Urokinase Solution
Global Urokinase market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Urokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Urokinase Market Overview
1.1 Urokinase Product Overview
1.2 Urokinase Market Segment by Type
1.2.1 Urokinase Powder
1.2.2 Urokinase Solution
1.3 Global Urokinase Market Size by Type
1.3.1 Global Urokinase Market Size Overview by Type (2018-2029)
1.3.2 Global Urokinase Historic Market Size Review by Type (2018-2023)
1.3.3 Global Urokinase Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Urokinase Sales Breakdown by Type (2018-2023)
1.4.2 Europe Urokinase Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Urokinase Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Urokinase Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Urokinase Sales Breakdown by Type (2018-2023)
2 Global Urokinase Market Competition by Company
2.1 Global Top Players by Urokinase Sales (2018-2023)
2.2 Global Top Players by Urokinase Revenue (2018-2023)
2.3 Global Top Players by Urokinase Price (2018-2023)
2.4 Global Top Manufacturers Urokinase Manufacturing Base Distribution, Sales Area, Product Type
2.5 Urokinase Market Competitive Situation and Trends
2.5.1 Urokinase Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Urokinase Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Urokinase as of 2022)
2.7 Date of Key Manufacturers Enter into Urokinase Market
2.8 Key Manufacturers Urokinase Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Urokinase Status and Outlook by Region
3.1 Global Urokinase Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Urokinase Historic Market Size by Region
3.2.1 Global Urokinase Sales in Volume by Region (2018-2023)
3.2.2 Global Urokinase Sales in Value by Region (2018-2023)
3.2.3 Global Urokinase Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Urokinase Forecasted Market Size by Region
3.3.1 Global Urokinase Sales in Volume by Region (2024-2029)
3.3.2 Global Urokinase Sales in Value by Region (2024-2029)
3.3.3 Global Urokinase Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Urokinase by Application
4.1 Urokinase Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Urokinase Market Size by Application
4.2.1 Global Urokinase Market Size Overview by Application (2018-2029)
4.2.2 Global Urokinase Historic Market Size Review by Application (2018-2023)
4.2.3 Global Urokinase Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Urokinase Sales Breakdown by Application (2018-2023)
4.3.2 Europe Urokinase Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Urokinase Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Urokinase Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Urokinase Sales Breakdown by Application (2018-2023)
5 North America Urokinase by Country
5.1 North America Urokinase Historic Market Size by Country
5.1.1 North America Urokinase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Urokinase Sales in Volume by Country (2018-2023)
5.1.3 North America Urokinase Sales in Value by Country (2018-2023)
5.2 North America Urokinase Forecasted Market Size by Country
5.2.1 North America Urokinase Sales in Volume by Country (2024-2029)
5.2.2 North America Urokinase Sales in Value by Country (2024-2029)
6 Europe Urokinase by Country
6.1 Europe Urokinase Historic Market Size by Country
6.1.1 Europe Urokinase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Urokinase Sales in Volume by Country (2018-2023)
6.1.3 Europe Urokinase Sales in Value by Country (2018-2023)
6.2 Europe Urokinase Forecasted Market Size by Country
6.2.1 Europe Urokinase Sales in Volume by Country (2024-2029)
6.2.2 Europe Urokinase Sales in Value by Country (2024-2029)
7 Asia-Pacific Urokinase by Region
7.1 Asia-Pacific Urokinase Historic Market Size by Region
7.1.1 Asia-Pacific Urokinase Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Urokinase Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Urokinase Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Urokinase Forecasted Market Size by Region
7.2.1 Asia-Pacific Urokinase Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Urokinase Sales in Value by Region (2024-2029)
8 Latin America Urokinase by Country
8.1 Latin America Urokinase Historic Market Size by Country
8.1.1 Latin America Urokinase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Urokinase Sales in Volume by Country (2018-2023)
8.1.3 Latin America Urokinase Sales in Value by Country (2018-2023)
8.2 Latin America Urokinase Forecasted Market Size by Country
8.2.1 Latin America Urokinase Sales in Volume by Country (2024-2029)
8.2.2 Latin America Urokinase Sales in Value by Country (2024-2029)
9 Middle East and Africa Urokinase by Country
9.1 Middle East and Africa Urokinase Historic Market Size by Country
9.1.1 Middle East and Africa Urokinase Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Urokinase Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Urokinase Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Urokinase Forecasted Market Size by Country
9.2.1 Middle East and Africa Urokinase Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Urokinase Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Syner-Med
10.1.1 Syner-Med Company Information
10.1.2 Syner-Med Introduction and Business Overview
10.1.3 Syner-Med Urokinase Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Syner-Med Urokinase Products Offered
10.1.5 Syner-Med Recent Development
10.2 Wanhua Biochem
10.2.1 Wanhua Biochem Company Information
10.2.2 Wanhua Biochem Introduction and Business Overview
10.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Wanhua Biochem Urokinase Products Offered
10.2.5 Wanhua Biochem Recent Development
10.3 Jiangxi Haoran Bio-Pharma
10.3.1 Jiangxi Haoran Bio-Pharma Company Information
10.3.2 Jiangxi Haoran Bio-Pharma Introduction and Business Overview
10.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Jiangxi Haoran Bio-Pharma Urokinase Products Offered
10.3.5 Jiangxi Haoran Bio-Pharma Recent Development
10.4 Jiangsu Aidea Pharmaceutical
10.4.1 Jiangsu Aidea Pharmaceutical Company Information
10.4.2 Jiangsu Aidea Pharmaceutical Introduction and Business Overview
10.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Jiangsu Aidea Pharmaceutical Urokinase Products Offered
10.4.5 Jiangsu Aidea Pharmaceutical Recent Development
10.5 Techpool
10.5.1 Techpool Company Information
10.5.2 Techpool Introduction and Business Overview
10.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Techpool Urokinase Products Offered
10.5.5 Techpool Recent Development
10.6 Microbic Biosystems
10.6.1 Microbic Biosystems Company Information
10.6.2 Microbic Biosystems Introduction and Business Overview
10.6.3 Microbic Biosystems Urokinase Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Microbic Biosystems Urokinase Products Offered
10.6.5 Microbic Biosystems Recent Development
10.7 LIVZON
10.7.1 LIVZON Company Information
10.7.2 LIVZON Introduction and Business Overview
10.7.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2018-2023)
10.7.4 LIVZON Urokinase Products Offered
10.7.5 LIVZON Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Urokinase Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Urokinase Industrial Chain Analysis
11.4 Urokinase Market Dynamics
11.4.1 Urokinase Industry Trends
11.4.2 Urokinase Market Drivers
11.4.3 Urokinase Market Challenges
11.4.4 Urokinase Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Urokinase Distributors
12.3 Urokinase Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
